Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-ICOS ligand Antibody-FITC (1W488) (Alias: LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-...)

Catalog No. TMAY-01901F Copy Product Info
🥰Excellent
Anti-ICOS ligand Antibody-FITC (1W488) is a FITC-conjugated Mouse antibody targeting ICOS ligand. Anti-ICOS ligand Antibody-FITC (1W488) can be used in FCM.

Anti-ICOS ligand Antibody-FITC (1W488)

Copy Product Info
🥰Excellent
Catalog No. TMAY-01901F
Alias LICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2

Anti-ICOS ligand Antibody-FITC (1W488) is a FITC-conjugated Mouse antibody targeting ICOS ligand. Anti-ICOS ligand Antibody-FITC (1W488) can be used in FCM.

Anti-ICOS ligand Antibody-FITC
(1W488)
Pack SizePriceUSA StockGlobal StockQuantity
25 T$817-10 days7-10 days
100 T$1057-10 days7-10 days
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-ICOS ligand Antibody-FITC (1W488) is a FITC-conjugated Mouse antibody targeting ICOS ligand. Anti-ICOS ligand Antibody-FITC (1W488) can be used in FCM.
SynonymsLICOS, inducible T-cell co-stimulator ligand, ICOSLG, ICOS-L, ICOSL, ICOS ligand, GL50, CD275, B7RP-1, B7RP1, B7-h2, B7H2
Ig Type
Mouse IgG1
Clone
1W488
Reactivity
Human
Specificity
Human B7-H2/ICOSLG
Verified Activity
Flow cytometric analysis of ICOSLG(CD275) expression on RPMI8226 cells.
Application
Recommended Dose
10 μl/Test, 0.1 mg/ml
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human ICOS Ligand / B7-H2 (rh ICOS Ligand / B7-H2; TMPY-01672; NP_056074.1; Met1-Ser258) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
PurificationProtein A
AppearanceLiquid
FormulationPBS solution containing 0.5% BSA and 0.03%ProClin300
Research BackgroundInducible co-stimulator ligand (ICOSL), also known as B7-H2, is a member of the B7 family of co-stimulatory molecules related to B7-1 and B7-2. It is a transmembrane glycoprotein with extracellular IgV and IgC domains and binds to ICOS on activated T cells, thus delivers a positive costimulatory signal for optimal T cell function. The structural features of ICOSL are crucial for its costimulatory function. The present study shows that ICOSL displays a marked oligomerization potential, resembling more like B7-1 than B7-2. B7-H2-dependent signaling may play an active role in a proliferative response rather than in cytokine and chemokine production. The CD28/B7 and ICOS/B7-H2 pathways are both critical for costimulating T cell immune responses. Deficiency in either pathway results in defective T cell activation, cytokine production, and germinal center formation.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: FCM AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint TargetsImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
FITC
Others Formats
Unconjugated/APC/PE
Antibody Types Available
4
Antigen Details
Immunogen
Recombinant Protein: Human ICOS Ligand / B7-H2 protein (TMPY-01672)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 12 months, do not freeze. Keep away from direct sunlight.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-ICOS ligand Antibody-FITC (1W488) | purchase Anti-ICOS ligand Antibody-FITC (1W488) | Anti-ICOS ligand Antibody-FITC (1W488) cost | order Anti-ICOS ligand Antibody-FITC (1W488)